Consultation on commissioning guidance for items which should not routinely be prescribed in primary care
Last year 1.1 billion prescription items were dispensed in primary care at a cost of £9.2billion. This cost coupled with finite resources means it is important that the NHS achieves the greatest value from the money that it spends. We know that across England there is significant variation in what is being prescribed and to whom. Often patients are receiving medicines which have been proven to be ineffective or in some cases dangerous, for which there are other more effective, safer and/or cheaper alternatives.
Clinical Commissioning Groups (CCGs) asked for a nationally co-ordinated approach to the development of commissioning guidance in this area to ensure consistency and address unwarranted variation.
The consultation proposes national guidance for CCGs on medicines which can be considered to be of low priority for NHS funding, provides you with information about the proposals and seeks your views on them. It will close on Saturday 21 October.
A number of engagement events for members of the public have been set up over the coming months. More details can be found on the NHS England website.